Arrythmia names Salvatore Emma, Jr. CEO of the Fitchburg, Mass.-based medical device company. Arrythmia Research Technology (NYSE:HRT) said on April 9 that Salvatore Emma, Jr. has been named president and CEO of the Fitchburg, Mass.-based medical device company. He was also appointed to the company’s board of directors.
